Extraordinary general meeting

Novozymes delivers stronger than expected Q1 results

Retrieved on: 
Wednesday, April 26, 2023
COVID-19, Novozymes, Extraordinary general meeting, Nutrition, Drink, CHR, Health, EBIT, Growth, Geography, Fine chemical, Agriculture, Bioenergy, Food

After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth.

Key Points: 
  • After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth.
  • “Novozymes is delivering stronger than expected results as we had a strong end to the first quarter including some impact from timing of orders.
  • The solid Q1 results confirms our confidence in the sales growth outlook of 4-7% for the year.
  • Full-year growth is expected to be driven by a combination of stronger pricing relative to 2022 as well as volume growth.

Pegasus Digital Mobility Acquisition Corp. Announces the Results of its Extraordinary General Meeting and Amendment of its Memorandum and Articles of Association

Retrieved on: 
Wednesday, April 19, 2023
Professional Services, Finance, Exercise, Tax, Acquisition, Extraordinary general meeting, NYSE, Sponsor, Security (finance)

Pegasus Digital Mobility Acquisition Corp. (NYSE: PGSS.U) (the "Company"), a special purpose acquisition company founded by Strategic Capital Fund Management, LLC (the "Sponsor"), today announced the results of its Extraordinary General Meeting.

Key Points: 
  • Pegasus Digital Mobility Acquisition Corp. (NYSE: PGSS.U) (the "Company"), a special purpose acquisition company founded by Strategic Capital Fund Management, LLC (the "Sponsor"), today announced the results of its Extraordinary General Meeting.
  • Stockholders holding 15,300,927 shares of Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Company's trust account.
  • As a result, $160,337,374.32 will be removed to pay such holders, with approximately $75,438,596.90 remaining in the Company's trust account.
  • Following the redemption, the Company's remaining number of Class A ordinary shares was 7,199,073.

New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2023

Retrieved on: 
Wednesday, April 19, 2023
Executive, Share repurchase, Marketing, Extraordinary general meeting, Conference call, ADS, Generally Accepted Accounting Principles (United States), GAAP, Stock, RSVP, Public expenditure, Company Names Tribunal, School, Student, PIN, Investment, City, Growth, Environment, Conference, Security (finance), Cryptocurrency, Bank, Clothing, Tutoring, Bottled water, Recycling

(3)  New Oriental provides net income / (loss) attributable to New Oriental, operating income / (loss) and net income /

Key Points: 
  • (3)  New Oriental provides net income / (loss) attributable to New Oriental, operating income / (loss) and net income /
    operating performance.
  • Simultaneously, our educational new business initiatives have sustained a strong momentum and generated meaningful profit in this fiscal quarter.
  • Financial Results for the Third Fiscal Quarter Ended February 28, 2023
    For the third fiscal quarter of 2023, New Oriental reported net revenues of US$754.2 million, representing a 22.8% increase year over year.
  • Net operating cash inflow for the third fiscal quarter of 2023 was approximately US$190.5 million and capital expenditures for the quarter were US$49.2 million.

Biophytis: Results of the Combined General Meeting on April 17, 2023

Retrieved on: 
Monday, April 17, 2023
CGM, Euronext Growth, Therapy, Ageing, AGM, Mass meeting, Extraordinary general meeting, Shareholder committee, EUR, COVID-19, Patient, Combined, Notifiable disease, General assembly, Clothing, Pharmaceutical industry

Thanks to the mobilization of shareholders, the CGM could be held on second call with a quorum of more than 20% of the shareholders present or represented.

Key Points: 
  • Thanks to the mobilization of shareholders, the CGM could be held on second call with a quorum of more than 20% of the shareholders present or represented.
  • The results of the votes of the combined General Meeting will be available on Biophytis’ website from April, 18TH 2023, under the section - Investors - General Assembly.
  • Stanislas Veillet, President, and CEO of Biophytis, said: « I would like to thank all the shareholders for their commitment and renewed trust.
  • I am very pleased that all the resolutions presented by the company during the Combined General Meeting were approved, which will allow us to move towards our goal of bringing our first drug against severe forms of Covid-19 to market in the coming months.”

EQS-News: PAION AG implements resolved capital reduction

Retrieved on: 
Saturday, April 15, 2023
ISIN, PA8, Aachen, Anesthesia, Extraordinary general meeting, Frankfurt Stock Exchange, Security (finance), Cryptocurrency

Aachen (Germany), 31 March 2023 – PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8), a specialty pharmaceutical company with innovative compounds for use in outpatient and in-hospital sedation, anesthesia and intensive care announces that the resolutions of the Extraordinary General Meeting of PAION AG on 25 January 2023 regarding the reductions of the share capital have been entered into the commercial register at the local court of Aachen on 14 March 2023.

Key Points: 
  • Aachen (Germany), 31 March 2023 – PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8), a specialty pharmaceutical company with innovative compounds for use in outpatient and in-hospital sedation, anesthesia and intensive care announces that the resolutions of the Extraordinary General Meeting of PAION AG on 25 January 2023 regarding the reductions of the share capital have been entered into the commercial register at the local court of Aachen on 14 March 2023.
  • The share capital of the Company, which amounted to EUR 71,336,992.00 at the Extraordinary General Meeting, was reduced to EUR 7,133,699.00 by registration of the resolutions of the Extraordinary General Meeting.
  • In case of a fractional settlement required for this purpose, the shareholders of PAION AG will be contacted by their custodian banks for the execution.
  • Expected from 12 April 2023, the converted shares will be traded under ISIN DE000A3E5EG5 and the stock exchange symbol PA8K.

DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting

Retrieved on: 
Wednesday, April 12, 2023
DBV Technologies, Mass meeting, DBV, Extraordinary general meeting, Fine chemical, Financial adviser, Holding company, Euronext

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today held its Ordinary and Extraordinary General Meeting.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today held its Ordinary and Extraordinary General Meeting.
  • The General Meeting was chaired by Michel de Rosen, Chairman of DBV Technologies.
  • The Company’s shareholders approved all resolutions submitted by the Board of Directors.
  • These resolutions and their results are posted on the Investors /Annual General Meetings section of the Company’s website: https://www.dbv-technologies.com/events/2023-annual-general-meeting/ .

Bulletin from Extraordinary General Meeting in NeoDynamics AB (publ)

Retrieved on: 
Monday, April 3, 2023
Disclosure, Mass meeting, SEK, Extraordinary general meeting, Security (finance), EU

STOCKHOLM, April 3, 2023 /PRNewswire/ -- NeoDynamics AB (publ) held an Extraordinary General Meeting today on 3 April 2023.

Key Points: 
  • STOCKHOLM, April 3, 2023 /PRNewswire/ -- NeoDynamics AB (publ) held an Extraordinary General Meeting today on 3 April 2023.
  • The Extraordinary General Meeting resolved in accordance with the following
    The boards proposal to authorize the board of directors to, on one or several occasions during the period up to the next annual general meeting, increase the Company's share capital through issues of new shares, warrants and/or convertible instruments, obtained 62% of the votes which is less than the required two thirds majority.
  • The Extraordinary General Meeting also resolved that the board of directors, for the period until the end of the next annual general meeting, shall consist of four directors (previously six) and no deputy directors (unchanged) and to re-elect Ingrid Salén (chairman), Carina Bolin, Claes Pettersson and Matthew E. Colpoys, Jr.
  • This disclosure contains information that NeoDynamics is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

Globant to Hold its Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders on April 19, 2023

Retrieved on: 
Tuesday, March 14, 2023
Meeting, Popular consultation to convene a referendum against decriminalization of abortion, Mass meeting, Extraordinary general meeting, NYSE, Security (finance), Shareholder

LUXEMBOURG, March 14, 2023 /PRNewswire/ -- Globant S.A. (NYSE: GLOB), a digitally native technology services company (the "Company"), announces that its Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders (collectively, the "General Meetings") are to be held on April 19, 2023.

Key Points: 
  • LUXEMBOURG, March 14, 2023 /PRNewswire/ -- Globant S.A. (NYSE: GLOB), a digitally native technology services company (the "Company"), announces that its Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders (collectively, the "General Meetings") are to be held on April 19, 2023.
  • The General Meetings will be held at the registered office of the Company at 37A, Avenue J.F.
  • Kennedy, L-1855, Luxembourg.
  • The Convening Notice including the agenda for the General Meetings, the form of proxy card and the relevant materials for the General Meetings are available at the Company's website at http://investors.globant.com .

EQS-News: beaconsmind AG: Convening of an Extraordinary General Meeting

Retrieved on: 
Saturday, March 11, 2023
Extraordinary general meeting, ISIN, Software as a service, LBM, CHF, Security (finance), Holding company

Zurich, Switzerland – 8 March 2023 – beaconsmind AG (ISIN: CH0451123589 – Ticker: MLBMD), a leading SaaS provider in the field of location-based marketing (LBM) & analytics, invites its shareholders to an Extraordinary General Meeting on 29 March 2023.

Key Points: 
  • Zurich, Switzerland – 8 March 2023 – beaconsmind AG (ISIN: CH0451123589 – Ticker: MLBMD), a leading SaaS provider in the field of location-based marketing (LBM) & analytics, invites its shareholders to an Extraordinary General Meeting on 29 March 2023.
  • The Extraordinary General Meeting is to resolve, among other things, on the election of Martin Niederberger and Jonathan Bertram Sauppe as additional members of the Board of Directors.
  • In addition, the Board of Directors proposes the introduction of a capital band between CHF 284,438.40 and CHF 426,657.60.
  • The invitation to the Extraordinary General Meeting is available for download at www.beaconsmind.com in the "Investor Relations" section.

OXUS ACQUISITION CORP. ANNOUNCES ADJOURNMENT OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO MARCH 2, 2023

Retrieved on: 
Tuesday, February 28, 2023
LLP, Extraordinary general meeting, Proxy, Vanderbilt Avenue, Security (finance), Ludlow Street (Manhattan), Class

Each such proposal is described in more detail in the definitive proxy statement related to the Extraordinary General Meeting filed by the Company with the Securities and Exchange Commission (the “SEC”) on February 10, 2023 (the “Definitive Proxy Statement”).

Key Points: 
  • Each such proposal is described in more detail in the definitive proxy statement related to the Extraordinary General Meeting filed by the Company with the Securities and Exchange Commission (the “SEC”) on February 10, 2023 (the “Definitive Proxy Statement”).
  • The record date for the Extraordinary General Meeting remains the close of business on January 25, 2023.
  • Shareholders who have not submitted their proxy for the Extraordinary General Meeting, or who wish to change or revoke their proxy, are urged to do so promptly.
  • Further information related to attendance, voting and the proposals to be considered and voted on at the Extraordinary General Meeting is described in the Definitive Proxy Statement.